REHOVOT, Israel, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that ...
CM24 combined with Opdivo and chemotherapy showed significant survival benefits in pancreatic cancer patients with CEACAM1 biomarkers. The study reported up to a 90% reduction in risk of death in ...
Purple’s innovative immuno-oncology, chemotherapy-free regimen reports encouraging Overall Survival data in 3 rd line PDAC patients Randomized Phase 2 study is enrolling as expected with initial Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results